ATE231184T1 - Impfstoffe gegen die pest - Google Patents

Impfstoffe gegen die pest

Info

Publication number
ATE231184T1
ATE231184T1 AT96905956T AT96905956T ATE231184T1 AT E231184 T1 ATE231184 T1 AT E231184T1 AT 96905956 T AT96905956 T AT 96905956T AT 96905956 T AT96905956 T AT 96905956T AT E231184 T1 ATE231184 T1 AT E231184T1
Authority
AT
Austria
Prior art keywords
pct
antigen
pestis
whole
vaccine
Prior art date
Application number
AT96905956T
Other languages
English (en)
Inventor
Richard William Titball
Ethel Diane Williamson
Sophie Emma Clare Leary
Petra Claire Farquhar Oyston
Alice Marie Bennett
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267623&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE231184(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9505059.7A external-priority patent/GB9505059D0/en
Priority claimed from GBGB9518946.0A external-priority patent/GB9518946D0/en
Priority claimed from GBGB9524825.8A external-priority patent/GB9524825D0/en
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE231184T1 publication Critical patent/ATE231184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96905956T 1995-03-13 1996-03-13 Impfstoffe gegen die pest ATE231184T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9505059.7A GB9505059D0 (en) 1995-03-13 1995-03-13 Vaccines
GBGB9518946.0A GB9518946D0 (en) 1995-09-15 1995-09-15 Vaccines
GBGB9524825.8A GB9524825D0 (en) 1995-12-05 1995-12-05 Vaccines
PCT/GB1996/000571 WO1996028551A1 (en) 1995-03-13 1996-03-13 Vaccines for plague

Publications (1)

Publication Number Publication Date
ATE231184T1 true ATE231184T1 (de) 2003-02-15

Family

ID=27267623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905956T ATE231184T1 (de) 1995-03-13 1996-03-13 Impfstoffe gegen die pest

Country Status (12)

Country Link
US (1) US5985285A (de)
EP (1) EP0815235B1 (de)
JP (1) JP3813173B2 (de)
CN (1) CN1155707C (de)
AT (1) ATE231184T1 (de)
AU (1) AU710181B2 (de)
CA (1) CA2215203C (de)
DE (1) DE69625802T2 (de)
DK (1) DK0815235T3 (de)
ES (1) ES2185762T3 (de)
PT (1) PT815235E (de)
WO (1) WO1996028551A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174628T1 (de) * 1992-07-31 1999-01-15 Medeva Holdings Bv Expression rekombinanter fusionsproteine in attenuierten bakterien
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6541011B2 (en) 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US7390619B1 (en) * 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
JP5124066B2 (ja) * 1999-03-24 2013-01-23 イギリス国 ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
GB9921275D0 (en) 1999-09-10 1999-11-10 Secr Defence Recombinant microorganisms
GB2369618B (en) * 1999-09-10 2004-06-02 Secr Defence Live vaccine expressing antigens using phoP or pagC promoters
US20050181063A1 (en) * 2000-03-22 2005-08-18 Alpar Hazire O. Pharmaceutical composition for administration to mucosal surfaces
US20030219737A1 (en) * 2000-03-28 2003-11-27 Bullard James M. Novel DNA polymerase III holoenzyme delta subunit nucleic acid molecules and proteins
WO2002092769A2 (en) * 2001-05-14 2002-11-21 Replidyne, Inc. System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
RU2190424C1 (ru) * 2001-07-18 2002-10-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Антигенный состав чумной химической вакцины
US7270827B2 (en) * 2001-10-26 2007-09-18 University Of Tennessee Research Foundation Multivalent streptococcal vaccine compositions and methods for use
GB0220257D0 (en) 2002-08-31 2002-10-09 Secr Defence Vaccine
GB0300885D0 (en) * 2003-01-15 2003-02-12 Secr Defence Pharmaceutical composition
US7344718B2 (en) 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
WO2005042017A1 (en) * 2003-10-22 2005-05-12 Id Biomedical Corporation Of Quebec Compositions and methods for activating innate and allergic immunity
US20070087013A1 (en) * 2003-12-09 2007-04-19 Donata Sizemore Orally-administered live bacterial vaccines for plague
US7875280B2 (en) * 2004-12-02 2011-01-25 The University Of Chicago Methods and compositions involving LcrV proteins
EP1827489B1 (de) * 2004-12-16 2012-10-31 Wake Forest University Health Sciences Verwendung von flagellin zur tumorimmuntherapie
CN101094685B (zh) * 2004-12-16 2016-01-13 韦克福里斯特大学健康科学院 鞭毛蛋白在鼠疫耶尔森氏菌的免疫疗法中的用途
CN101337069B (zh) * 2005-11-25 2012-07-25 中国药品生物制品检定所 复合鼠疫疫苗及其制备方法
GB0525213D0 (en) * 2005-12-12 2006-01-18 Secr Defence Vaccine
US7815911B1 (en) * 2006-10-10 2010-10-19 University Of Kentucky Research Foundation Compositions and methods for treating Yersinia pestis infection
US10174100B1 (en) * 2006-11-06 2019-01-08 Microvax, Llc Multivalent DNA composition for Yersinia pestis
WO2009009759A2 (en) * 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
GB0717187D0 (en) * 2007-09-04 2007-10-17 Novartis Ag Compositions comprising yersinia pestis antigens
CN101531710B (zh) * 2009-04-24 2012-05-09 中国疾病预防控制中心传染病预防控制所 rF1抗原及其制备方法与应用
CN101985610A (zh) * 2010-10-26 2011-03-16 中国人民解放军军事医学科学院微生物流行病研究所 一种伤寒沙门氏菌菌蜕、制备方法及作为递送系统的应用
CN101979504A (zh) * 2010-10-26 2011-02-23 中国人民解放军军事医学科学院微生物流行病研究所 鼠疫耶尔森氏菌菌蜕、其制备方法及作为疫苗的应用
US9211327B2 (en) 2011-06-22 2015-12-15 University Of North Dakota Use of YSCF, truncated YSCF and YSCF homologs as adjuvants
EP2852405B1 (de) * 2012-05-23 2019-03-13 The United States of America, as represented by The Secretary, Department of Health and Human Services Salmonella typhi ty21a zur expression eines yersinia pestis f1-v-fusionsproteins und verwendungen davon
US9328149B2 (en) * 2013-07-12 2016-05-03 The Catholic University Of America Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
CN106606775A (zh) * 2015-10-27 2017-05-03 格里菲斯大学 脂质体a群链球菌疫苗
RU2671525C2 (ru) * 2015-12-07 2018-11-01 Российская Федерация, от имени которой выступает Министерство обороны Российской Федерации Рекомбинантный вакцинный препарат пролонгированного действия для профилактики чумы у млекопитающих и человека и способ его получения
CN114929750B (zh) 2019-09-13 2024-11-22 芝加哥大学 用于治疗葡萄球菌感染的方法和组合物
CN114560932B (zh) * 2022-02-18 2023-09-12 中国人民解放军军事科学院军事医学研究院 一株鼠疫中和抗体及其应用

Also Published As

Publication number Publication date
AU4951196A (en) 1996-10-02
ES2185762T3 (es) 2003-05-01
CN1155707C (zh) 2004-06-30
EP0815235A1 (de) 1998-01-07
CN1184505A (zh) 1998-06-10
AU710181B2 (en) 1999-09-16
DE69625802T2 (de) 2003-11-13
US5985285A (en) 1999-11-16
CA2215203C (en) 2008-12-09
EP0815235B1 (de) 2003-01-15
PT815235E (pt) 2003-06-30
CA2215203A1 (en) 1996-09-19
DK0815235T3 (da) 2003-04-22
DE69625802D1 (de) 2003-02-20
JP3813173B2 (ja) 2006-08-23
JPH11501654A (ja) 1999-02-09
WO1996028551A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
ATE231184T1 (de) Impfstoffe gegen die pest
RU94046232A (ru) Вакцинная композиция, применение композиции, способы лечения, способ приготовления композиции
FR2620941B1 (fr) Vaccin contenant des adjuvants et des antigenes tumoraux
DE69327656D1 (de) Impfstoffe gegen die aujeskyskrankheit und sonstige tierkrankheiten, die pseudorabies virusmutanten enthalten
KR970707281A (ko) 풀리뉴클레오티드 결핵 백신(A polynucleotide tuberculosis vaccine)
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
DE69309479D1 (de) Markiertes monocyte-chemoattractant-proteinmaterial und medizinische anwendung
ATE320444T1 (de) Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren
DE69031351D1 (de) Zubereitungen und behandlungen von pneumonia in tieren
DE60004334D1 (de) Impfstoffzusammensetzung auf basis von partikeln
KR970703428A (ko) Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv)
DE69230855D1 (de) System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
EP0687728A3 (de) Reovirus Stamm 2177 und diesen enthaltende Vakzine
EA200300535A1 (ru) Способ получения антигенных структур, усиливающих специфическую перекрестную реактивность
ATE205397T1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
RU2039569C1 (ru) Способ профилактики бруцеллеза и кампилобактериоза крупного рогатого скота
RU2190424C1 (ru) Антигенный состав чумной химической вакцины
ATE297985T1 (de) Orale impfstoffe gegen yersinia pestis infektionen
Whyte et al. Leucocyte entry and endothelial E-selectin expression following intradermal Propionibacterium acnes administration
DE68918127D1 (de) Peptidbehandlung von hartnäckigen Infektionskrankheiten.
EP0373388A3 (de) Penemderivate und Verfahren zu ihrer Herstellung
UA31873A (uk) Спосіб вакцино-профілактики птиці
Okuda et al. Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination
Mukerjee et al. Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0815235

Country of ref document: EP